NOTA:FRA
Novartis
146,00 €
arrow_upward
+1,39%(+2,00) 1 d.
5. 11., 8:48:45 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre NOTA…
Otvoriť
146,00 €
Vysoká
146,00 €
Nízka
146,00 €
Trh. kap.
272,83 mld.
Priem. obj.
12,00
Objem
0,00
Max. za 52 týž.
146,00 €
Min. za 52 týž.
105,50 €
Počet zamestnancov
75 tis.
Otvoriť
146,00 €
Vysoká
146,00 €
Nízka
146,00 €
Trh. kap.
272,83 mld.
Priem. obj.
12,00
Objem
0,00
Max. za 52 týž.
146,00 €
Min. za 52 týž.
105,50 €
Počet zamestnancov
75 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
WSJ
·
pred 3 hodinami
Novartis Raises Guidance Despite Drug-Trial Setbacks Hitting Profit
GuruFocus
·
pred 10 hodinami
Novartis AG (NVS) Shares Surge 3.6% -- What GF Score of 82 Tells Investors
Traders Union
·
pred 14 hodinami
What's behind Novartis's latest 3.3% stock surge?
TradingKey
·
pred 15 hodinami
Novartis AG Stock (NVS) Moved Up by 3.34% on Nov 4: A Full Analysis
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Informácie o subjekte Novartis
Generálny riaditeľVasant Narasimhan
Zamestnanci75,3 tis.
Dátum založenia7. 3. 1996
Hlavné sídloBazilej, Bazilej-mesto, Švajčiarsko
Odvetvie-
Industry-
Webnovartis.com